Indeed, elevated BLT2 expression correlated with poor prognosis in clear cell renal cell carcinoma (ccRCC) [205] and in triple‐negative breast cancer [206], by stimulating cancer cell proliferation, metastatic potential, and apoptosis resistance [205, 207, 208, 209]. This evidence concerns the gene LTB4R2 and cancer.